My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 216

    1.

    Cerivastatin improves insulin sensitivity and insulin secretion in early-state obese type 2 diabetes.

    Paniagua JA, López-Miranda J, Escribano A, Berral FJ, Marín C, Bravo D, Paz-Rojas E, Gómez P, Barcos M, Moreno JA, Pérez-Jiménez F.

    Diabetes. 2002 Aug;51(8):2596-603.PMID: 12145176 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Oxidized-LDL levels are changed during short-term serum glucose variations and lowered with statin treatment in early Type 2 diabetes: a study of endothelial function and microalbuminuria.

    Paniagua JA, López-Miranda J, Pérez-Martínez P, Marín C, Vida JM, Fuentes F, Fernández de la Puebla RA, Pérez-Jiménez F.

    Diabet Med. 2005 Dec;22(12):1647-56.PMID: 16401307 [PubMed - indexed for MEDLINE]Related articles

    3.

    Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes mellitus independently of weight loss.

    Maheux P, Ducros F, Bourque J, Garon J, Chiasson JL.

    Int J Obes Relat Metab Disord. 1997 Feb;21(2):97-102.PMID: 9043962 [PubMed - indexed for MEDLINE]Related articles

    4.

    Benfluorex decreases insulin resistance and improves lipid profiles in obese type 2 diabetic patients.

    Bianchi R, Bongers V, Bravenboer B, Erkelens DW.

    Diabetes Metab Rev. 1993 Nov;9 Suppl 1:29S-34S.PMID: 8299486 [PubMed - indexed for MEDLINE]Related articles

    5.

    Bromocriptine: a novel approach to the treatment of type 2 diabetes.

    Pijl H, Ohashi S, Matsuda M, Miyazaki Y, Mahankali A, Kumar V, Pipek R, Iozzo P, Lancaster JL, Cincotta AH, DeFronzo RA.

    Diabetes Care. 2000 Aug;23(8):1154-61.PMID: 10937514 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.

    Halberstam M, Cohen N, Shlimovich P, Rossetti L, Shamoon H.

    Diabetes. 1996 May;45(5):659-66. Erratum in: Diabetes 1996 Sep;45(9):1285. PMID: 8621019 [PubMed - indexed for MEDLINE]Related articles

    7.

    NIDDM in the elderly.

    Meneilly GS, Elliott T, Tessier D, Hards L, Tildesley H.

    Diabetes Care. 1996 Dec;19(12):1320-5.PMID: 8941457 [PubMed - indexed for MEDLINE]Related articles

    8.

    Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.

    Meneilly GS, Elliott T.

    Diabetes Care. 1999 Jan;22(1):112-8.PMID: 10333911 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

    DeFronzo RA, Barzilai N, Simonson DC.

    J Clin Endocrinol Metab. 1991 Dec;73(6):1294-301.PMID: 1955512 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effect of pinitol treatment on insulin action in subjects with insulin resistance.

    Davis A, Christiansen M, Horowitz JF, Klein S, Hellerstein MK, Ostlund RE Jr.

    Diabetes Care. 2000 Jul;23(7):1000-5.PMID: 10895854 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.

    Basu R, Shah P, Basu A, Norby B, Dicke B, Chandramouli V, Cohen O, Landau BR, Rizza RA.

    Diabetes. 2008 Jan;57(1):24-31. Epub 2007 Oct 3.PMID: 17914032 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Similar insulin sensitivity in NIDDM patients with normo- and microalbuminuria.

    Nielsen S, Schmitz O, Orskov H, Mogensen CE.

    Diabetes Care. 1995 Jun;18(6):834-42.PMID: 7555510 [PubMed - indexed for MEDLINE]Related articles

    13.

    Thalidomide impairs insulin action on glucose uptake and glycogen synthesis in patients with type 2 diabetes.

    Iqbal N, Zayed M, Boden G.

    Diabetes Care. 2000 Aug;23(8):1172-6.PMID: 10937517 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus.

    Acerini CL, Harris DA, Matyka KA, Watts AP, Umpleby AM, Russell-Jones DL, Dunger DB.

    Metabolism. 1998 Dec;47(12):1481-9.PMID: 9867078 [PubMed - indexed for MEDLINE]Related articles

    15.

    Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.

    Perriello G, Misericordia P, Volpi E, Pampanelli S, Santeusanio F, Brunetti P, Bolli GB.

    J Clin Endocrinol Metab. 1995 Aug;80(8):2464-9.PMID: 7629243 [PubMed - indexed for MEDLINE]Related articles

    16.

    Trandolapril does not improve insulin sensitivity in patients with hypertension and type 2 diabetes: a double-blind, placebo-controlled crossover trial.

    Petrie JR, Morris AD, Ueda S, Small M, Donnelly R, Connell JM, Elliott HL.

    J Clin Endocrinol Metab. 2000 May;85(5):1882-9.PMID: 10843169 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study.

    Koska J, Ortega E, Bunt JC, Gasser A, Impson J, Hanson RL, Forbes J, de Courten B, Krakoff J.

    Diabetologia. 2009 Mar;52(3):385-93. Epub 2008 Dec 23.PMID: 19104769 [PubMed - indexed for MEDLINE]Related articles

    18.

    Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus. Influence of body weight.

    Volk A, Renn W, Overkamp D, Mehnert B, Maerker E, Jacob S, Balletshofer B, Häring HU, Rett K.

    Exp Clin Endocrinol Diabetes. 1999;107(2):140-7.PMID: 10320055 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic men.

    Tran D, Lowy A, Howes JB, Howes LG.

    Diabetes Obes Metab. 2005 May;7(3):273-81.PMID: 15811145 [PubMed - indexed for MEDLINE]Related articles

    20.

    Five weeks of insulin-like growth factor-I treatment does not alter glucose kinetics or insulin sensitivity during a hyperglycemic clamp in older women.

    Braun B, Friedlander AL, Pollack M, Butterfield GE, Marcus R, Hoffman AR.

    Metabolism. 2003 Sep;52(9):1182-90.PMID: 14506625 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity